• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

FirstMark

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AISurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AISurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI
    17 Feb 2026

    SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI

    SurrealDB develops a multi-model database that combines different data types into a single system for storing and managing complex information. It is designed to help developers and AI systems maintain context, relationships, and memory as data grows in scale and complexity.

    Synthesia secures £150m in Series D funding led by NEA to advance AI video for enterprise communicationsSynthesia secures £150m in Series D funding led by NEA to advance AI video for enterprise communications
    Synthesia
    15 Jan 2025

    Synthesia secures £150m in Series D funding led by NEA to advance AI video for enterprise communications

    Synthesia develops enterprise video software that allows companies to create, localise and personalise video communications at scale, supporting internal training, product education and global knowledge sharing without traditional production costs.

FirstMark
    • Enterprise
    • AI
  • 1(12 months)
  • firstmark.com
  • Update Information

More venture news

  • Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
    Brainomix
    24 Feb 2026

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis

    ExtensionHealth
  • Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy
    Centauri Therapeutics
    24 Feb 2026

    Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy

    ExtensionLife Sciences
  • SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI
    SurrealDB
    17 Feb 2026

    SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI

    ExtensionEnterprise

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn